Do GWAS-Identified Risk Variants for Chronic Lymphocytic Leukemia Influence Overall Patient Survival and Disease Progression?
Cabrera-Serrano A, Sánchez-Maldonado J, Ter Horst R, Macauda A, García-Martín P, Benavente Y, Landi S, Clay-Gilmour A, Niazi Y, Espinet B, Rodríguez-Sevilla J, Pérez E, Maffei R, Blanco G, Giaccherini M, Cerhan J, Marasca R, López-Nevot M, Chen-Liang T, Thomsen H, Gámez I, Campa D, Moreno V, de Sanjosé S, Marcos-Gragera R, García-Álvarez M, Dierssen-Sotos T, Jerez A, Butrym A, Norman A, Luppi M, Slager S, Hemminki K, Li Y, Berndt S, Casabonne D, Alcoceba M, Puiggros A, Netea M, Försti A, Canzian F, Sainz J